Searched for
LICENSING AND COMMERCIALISATION AGREEMENT
Oxford University strikes new malaria vaccine pact with Serum Institute of IndiaOxford University and Serum Institute of India are collaborating on a new malaria vaccine, R78C. This partnership aims to create a more eff...- Sun Pharma shares rally 9% in two days after $12-bn Organon deal. Here's what Morgan Stanley, other brokerages saySun Pharmaceutical Industries' shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in...
- Zydus Lifesciences inks licensing, commercialisation pact with RK PharmaZydus Lifesciences has partnered with RK Pharma Inc of the US. They will collaborate on a new sterile injectable oncology supportive care p...
- Lupin signs $50 million licensing deal with Zentiva to commercialise Certolizumab Pegol across global marketsLupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The agreement grants...
- Zydus Lifesciences in pact with Synthon for specialty oncology product in USZydus Lifesciences has signed an exclusive agreement with Synthon for the development and commercialisation of a novel oncology product, fo...
- Aurobindo joins hands with global pharma player to develop respiratory productsAurobindo Pharma's US subsidiary has partnered with a global pharmaceutical company to develop and sell respiratory products. The collabora...
- Dr Reddy's inks licensing pact with Takeda to sell gastrointestinal drugNew Delhi: Dr Reddy's Laboratories, a Hyderabad-based firm, and Takeda Pharmaceutical entered a non-exclusive licensing pact to market 10mg...
- Dr Reddy's signs in-licensing pact with Ingenus Pharmaceuticals for cancer treatment injectionDr Reddy's Laboratories Ltd has signed a licensing agreement with US-based Ingenus Pharmaceuticals to commercialize Cyclophosphamide inject...
- Biocon Biologics inks out-licensing agreement with Yoshindo IncUnder the terms of this deal, Japan-based Yoshindo gets exclusive commercialisation rights in Japan for Ustekinumab and Denosumab -- develo...
- Torrent & Aurobindo receive licenses to sell Pfizer's COVID pill Paxlovid in India, low income countriesThe oral COVID-19 treatment comprises of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating and ritonavir...
- ICMR designs kit for omicron detection; invites EOI from manufacturers for its commercialisation"ICMR is the owner of the said technology, including any underlying intellectual property(ies) and commercialisation rights. ICMR is lawful...
- Sun Pharma, Ferring Pharmaceuticals ink pact to introduce obstetric drug in IndiaAs per the agreement, Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name Caritec...
- Lupin inks distribution pact with 3 firms to commercialise NaMuscla in EuropeExeltis Healthcare SL, Cresco Pharma BV and Macure Pharma ApS will commercialise NaMuscla for the symptomatic treatment of myotonia in adul...
- Zydus & CMS enter pact for Desidustat in Greater ChinaThe agreement is for Desidustat, a novel oral HIF-PH inhibitor for the treatment of anemia in patients with Chronic Kidney Disease (CKD) no...
- Sun Pharma, US-based Rockwell Medical enter into licensing pact for Triferic in IndiaAs per the terms of the agreement, Sun Pharma will be the exclusive development and commercialisation partner for Triferic during the term ...
- Sun Pharma arm enters pact with China Medical SystemChina Medical System will pay Sun Pharma an initial upfront payment, regulatory and sales milestone payments, and royalties on net sales, t...
- Sun Pharma rises after licensing deal with AlmirallAt 11:01 am, shares of the company were trading at Rs 817.80 per share, up 1.24 per cent from its previous close on the Bombay Stock Exchan...
- Jubilant Life signs $180 mn outlicensing deal with Checkpoint"The pact includes an upfront payment of $2 mn and contingent pre-clinical, clinical and regulatory payments including commercials up to $1...
- Alembic Pharma arm ties up with Novartis for drug developmentAlembic Pharmaceuticals group firm Rhizen Pharmaceuticals SA has entered into an exclusive worldwide license agreement with Novartis.
- Orchid enters into $100 mn licensing agreement with MerckDrug-maker Orchid Chemicals on Monday said it has entered into a USD 100-million (about Rs 470 crore) licensing agreement with Merck & Co f...
Load More
